Susceptibility of HIV-1 Plasma Virus to Complement-Mediated Lysis: Evidence for a Role in Clearance of Virus in Vivo

Journal of Immunology

Volumn 157, Issue 4, 1996, Pages 1791-1798

  Sullivan, Brenda L ^a   Knopoff, Elissa J ^a   Saifuddin, Mohammed ^a   Takefman, Daniel M ^a   Saarloos, Mary Nel ^a   Sha, Beverly E ^b   Spear, Gregory T ^a  

^a RUSH UNIVERSITY   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD46 PROTEIN, HUMAN; CD59 ANTIGEN; COMPLEMENT; DECAY ACCELERATING FACTOR; LEUKOCYTE ANTIGEN; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN; STAPHYLOCOCCUS PROTEIN A;

ARTICLE; CELL LINE; CHEMISTRY; COMPLEMENT CLASSICAL PATHWAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHYSIOLOGY; T LYMPHOCYTE; VIREMIA; VIRION; VIROLOGY;

ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; CELL LINE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOSORBENT TECHNIQUES; MEMBRANE GLYCOPROTEINS; STAPHYLOCOCCAL PROTEIN A; T-LYMPHOCYTES; VIREMIA; VIRION;

EID: 0030586652     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Aoki-Sei, S., R. Yarchoan, S. Kageyama, D. T. Hoekzema, J. M. Pluda, K. M. Wyvill, S. Broder, and H. Mitsuya. 1992. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res. Hum. Retroviruses 8:1263.
2. Escaich, S., J. Ritter, P. Rougier, D. Lepot, J. P. Lamelin, M. Sepetjan, and C. Trepo. 1991. Plasma viremia as a marker of viral replication in HIV-infected individuals. AIDS 5:1189.
3. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type I infection. Nature 373:117.
4. Ho, D. D., A. U. Newmann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasmy virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123.
5. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho, 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582.
6. Arvieuz, J., H. Yssel, and M. G. Colomb. 1988. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 65:229.
7. Kulkarni, A. B., A. Mullbacher, and R. V. Blanden. 1991. Functional analysis of macrophages, B cells and splenic dendritic cells as antigen-presenting cells in West Nile virus-specific murine T lymphocyte proliferation. Immunol. Cell Biol. 69:71.
8. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127.
9. + T-helper cells. Am. J. Pathol. 140:15.
10. Pantaleo, G., C. Graziosi, L. Butini, P. A. Pizzo, S. M. Schnittman, D. P. Kotler, and A. S. Fauci. 1991. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88:9838.
11. B. D. Walker. 1994. The rationale for immunotherapy in HIV-1 infection. J. Acquir. Immun. Def. Syndr. 7 (Suppl. 1):S6.
12. Mann, D. L., F. Lasane, M. Popovic, L. O. Arthur, W. G. Robey, W. A. Blattner, and M. J. Newman. 1987. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J. Virol. 138:2640.
13. Meyarrd, L., S. A. Otto, R. R. Junker, M. J. Mijnster, R. P. M. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science 257:217.
14. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp 120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099.
15. Koup, R. A., J. E. Robinson, Q. V. Nguyen, C. A. Pilora, R. Blais, A. Roskey, D. Panicali, and J. L. Sullivan. 1991. Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1. AIDS 5:1309.
16. Hober, D., A. Jewett, and B. Bonavida. Lysis of uninfected HIV-1 gp 120-coated peripheral blood-derived T lymphocytes by monocyte-mediated antibody-dependent cellular cytotoxicity. 1995. FEMS Immunol. Med. Microbiology 10:83.
17. Parker, S. J., T. A. Sadlon, and D. L. Gordon. 1995. Enhancement of NK cell-mediated antibody-dependent lysis of recombinant gp 120-coated CD4 cells by complement. J. Infect. Dis. 171:186.
18. Weinbold, K. J., H. K. Lyerly, S. D. Stanley, A. A. Austin, T. J. Matthews, and D. P. Bolognesi. 1989. HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142:3091.
19. + T cells of HIV infected individuals: a possible role in AIDS pathogenesis. Int. Immunol. 6:1361.
20. Laman, J. D., E. Claassen, N. Van Rooijen, and Wim, J. A. Boersma. 1989. Immune complexes on follicular dendritic cells as a target for cytolytic cells in AIDS. AIDS 3:543.
21. Cooper, N. R., and M. Welsh. 1979. Antibody and complement-dependent viral neutralization. Springer Semin. Immunopathol. 2:285.
22. Cooper, N. R., and G. R. Nemerow. 1986. Complement-dependent mechanisms of virus neutralization. In Immunobiology of the Complement System. Academic Press. New York, pp 139-162.
23. Spear, G. T., D. M. Takefman, B. L. Sullivan, A. L. Landay, and S. Zolla-Pazner. 1993. Complement activation by human monoclonal antibodies to human immunodeficiency virus. J. Virol. 67:53.
24. Robinson, W. E., D. C. Montefiori, and W. M. Mitchell. 1988. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1:790.
25. June, R. A., S. Z. Schade, M. J. Bankowski, M. Kuhns, A. McNamara, T. F. Lint, A. L. Landay, and G. T. Spear. 1991. Complement and antibody mediate enhancement of HIV-1 infection by increasing virus binding and provirus formation. AIDS 5:269.
26. Solder, B. M., T. F. Schulz, P. Hengster, J. Lower, C. Larcher, G. Bitterlich, R. Kurth, H. Wachter, and M. P. Dierich. 1989. HIV and HIV-infected cells differentially activate the human complement system independent of antibody. Immunol. Lett. 22:135.
27. Robinson, W. E., Jr., D. C. Montefiori, and W. M. Mitchell. 1990. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 175:600.
28. Prohaszka, Z., T. Hdivegi, E. Ujhelyi, H. Stoiber, M. P. Dierich, C. Susal, and G. Fust. 1995. Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. Immunology 85:184.
29. Stoiber, H., N. M. Thielens, C. Ebenbichler, G. J. Arlaud, and M. P. Dierich. 1994. The envelope glycoprotein of HIV-1 gp120 and human complement protein Clq bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology. Eur. J. Immunol. 24:294.
30. Stoiber, H., C. Ebenbichler, R. Schneider, J. Janatova, and M. P. Dierich. 1995. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS 9:19.
31. Ebenbichler, C. P., N. M. Thielens, R. Vornhagen, P. Marschang, G. J. Arlaud, and M. P. Dierich. 1991. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct Cl binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174:1417.
32. Ezekowitz, R. A., M. Kuhlman, J. E. Groopman, and R. A. Byrn. 1989. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 169:185.
33. Haurum, J. S., S. Thiel, I. M. Jones, P. B. Fischer, S. B. Laursen, and J. C. Jensenius. 1993. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7:1307.
34. H3 gene products: natural ligands for HIV gp 120. Science 261:1588.
35. Spear, G. T., B. L. Sullivan, A. L. Landay, and T. F. Lint. 1990. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. J. Virol. 64:5869.
36. Spear, G. T., A. L. Landay, B. L. Sullivan, B. Dittel, and T. F. Lint. 1990. Activation of complement on the surface of cells infected by human immunodeficiency virus. J. Immunol. 144:1490.
37. Robinson, W. E., Jr., D. C. Montefiori, D. H. Gillespie, and W. M. Mitchell. 1989. Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA synthesis and infectious virus release. J. Acquir. Immun. Def. Syndr. 2:33.
38. Gregersen, J. P., S. Sehdi, A. Baur, and J. Hilfenhaus. 1990. Antibody and complement-mediated lysis of HIV-infected cells and inhibition of viral replication. J. Med. Virol. 30:287.
39. Saifuddin, M., C. J. Parker, M. E. Peeples, M. K. Gorny, S. Zolla-Pazner, M. Chassemi, I. A. Rooney, J. P. Atkinson, and G. T. Spear. 1995. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived und primary isolates of HIV-1. J. Exp. Med. 182:501.
40. Stoiber, H., C. Pinter, A. G. Siccardi, A. Clivio, and M. P. Dierich. 1996. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J. Exp. Med. 183:307.
41. Montefiori, D. C., R. J. Cornell, J. V. Zhou, J. T. Zhou, V. M. Hirsch, and P. R. Johnson. 1994. Complement control proteins CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205:82.
42. Weiler, J. M., and R. J. Linhardt. 1991. Antithrombin III regulates complement activity in vitro. J. Immunol. 146:3889.
43. Kinoshita, T. 1991. Biology of complement: the overture. Immunol. Today 12:291.
44. Morgan, B. P. 1994. Clinical complementology: recent progress and future trends. Eur. J. Clin. Invest. 24:219.
45. Laurence, J., A. Saunders, and J. Kulkowky. 1987. Characterization of clinical association of antibody inhibitory to HIV reverse transcriptase activity. Science 235:1501.
46. Arthur, L. O., J. W. Bess Jr., R. C. Sowder II, R. E. Benveniste, D. L. Mann, J. C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935.
47. Banpour, B., J. Sernatinger, and J. A. Levy. 1986. The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology 152:268.
48. Layne, S. P., M. J. Merger, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695.
49. Liu, H., X. Wu, M. Newman, G. M. Shaw, B. H. Hahn, and J. C. Kappes. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69:7630.
50. McGrath, M., O. Witte, T. Pincus, and I. L. Weissman. 1978. Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity. J. Virol. 25:923.
51. Holguin, M. H., L. R. Fredrick, N. J. Bernshaw, L. A. Wilcox, and C. J. Parker. 1989. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J. Clin. Invest. 84:7.
52. Wilcox, L. A., J. L. Ezzell, N. J. Brenshaw, and C. J. Parker. 1991. Molecular basis from the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Blood 78:820.
53. Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749.
54. Gartnew, S., and M. Popovic. 1990. Virus isolation and production. In Techniques in HIV Research. A. Aldovini and B. D. Walker, eds. Stockton Press, New York, pp. 53-70.
55. Montefiori, D. C., W. E. Robinson, Jr., S. S. Schuffman, and W. M. Mitchell. 1988. Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. J. Clin. Microbiol. 26:231.
56. Spear, G. T., D. M. Takefman, B. L. Sullivan, A. L. Landay, M. B. Jennings, and J. R. Carlson. 1993. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Virology 195:475.
57. Saifuddin, M., M. Ghassemi, C. Patki, C. J. Parker, and G. T. Spear. 1994. Host cell components affect the sensitivity of HIV-1 to complement-mediated virolysis. AIDS Res. Hum. Retroviruses 10:829.
58. Muller-Eberhard, H. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:321.
59. Hirsch, R. L. 1982. The complement system: its importance in the host response to viral infection. Microbiol. Rev. 46:71.
60. Perricone, R., L. Fontana, C. De Carolis, C. Carini, M. C. Sirianni, and F. Aiuti. 1987. Evidence for activation of complement in patients with AIDS-related complex and/or lymphadenopathy syndrome. Clin. Exp. Immunology 70:500.
61. Inada, Y., M. Lange, G. F. McKinley, J. A. Sonnabend, J. W. Fonville, T, Kanemitsu, M. Tanaka, and W. S. Clark. 1986. Hematologic correlates and the role of erythrocyte CR1 (C3b receptor) in the development of AIDS. AIDS Res. 2:235.
62. Carini, C., R. Perricone, C. Fratazzi, L. Fontana, C. DeCarolis, R. D'Amelio, M. C. Sirianni, and F. Aiuti. 1989. Complement activation is associated with the presence of specific human immunodeficiency virus (HIV)-anti-HIV immune complexes in patients with acquired immunodeficiency syndrome-related complex or lymphoadenopathy syndrome. Scand. J. Immunol. 30:347.
63. Lin, R. Y., O. Wildfeuer, M. M. Franklin, and K. Candido. 1988. Hypocomplementemia and human immunodeficiency virus infection. Int. Arch. Allergy Appl. Immunol. 87:40.
64. Tausk, F. A., J. A. McCutchan, P. Spechko, R. D. Schreiber, and I. Gigli. 1986. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for AIDS. J. Clin. Invest. 78:977.
65. Saarloos, M. N., R. E. Koenig, and G. T. Spear. 1995. Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus (HTLV) with HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Infect. Dis. 172:1095.
66. Senaldi, G., M. Peakman, T. McManus, E. T. Davies, D. E. H. Tee, and D. Vergani. 1990. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. J. Infect Dis. 162:1227.
67. Fust, G., E. Ujhelyi, T. Hidvegi, K. Paloczi, R. Mihalik, S. Hollan, K. Nagy, and M. Kirschfink. 1991. The complement system in HIV-1 disease. Immunol. Invest. 20:231.
68. Holodniy, M., L. Mole, B. Yen-Lieberman, D. Margolis, C. Starkey, R. Carroll, T. Spahlinger, J. Todd, and J. B. Jackson. 1995. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in Vacutainer CPT, Vacutainer PPT, and standard Vacutainer tubes. J. Clin. Microbiol. 33:1562.
69. Olszewski, W. L., A. Engeset, and H. Lukasiewicz. 1977. Immunoglobulins, complement and lysozyme in leg lymph of normal men. Scand. J. Clin. Lab. Invest. 37:669.
70. Olszewski, W. L., and A. Engeset. 1978. Haemolytic complement in peripheral lymph of normal men. Clin. Exp. Immunol. 32:392.
71. Vogt, W., B. Damerau, B. Luhmann, D. Hesse, and Y. Haller. 1986. Complement activation in human lymph: modulation by the contact activation system and by leukocytes. Int. Arch. Allergy Appl. Immunol. 79:423.
72. Heath, S. L., J. G. Twe, John G. Tew, A. K. Szakal, and G. F. Burton. 1995. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377:740.
73. Schmitz, J., J. Lunzen, K. Tenner-Racz, G. Grobschupff, P. Racz, H. Schmitz, M. Dietrich, and F. T. Hufert. 1994. Follicular Dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. J. Immunol. 153:1352.
74. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
75. Joling, P., L. J. Bakker, J. A. G. Van Strijp, T. Meerloo, L. de Graaf, M. E. M. Dekker, J. Goudsmit, J. Verhoef, and H. J. Schuurman. 1993. Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. J. Immunol. 150:1065.
76. Piatak, M., M. S. Sagg, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS 7:S65.